These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

176 related articles for article (PubMed ID: 27400756)

  • 41. Structures of endothiapepsin-fragment complexes from crystallographic fragment screening using a novel, diverse and affordable 96-compound fragment library.
    Huschmann FU; Linnik J; Sparta K; Ühlein M; Wang X; Metz A; Schiebel J; Heine A; Klebe G; Weiss MS; Mueller U
    Acta Crystallogr F Struct Biol Commun; 2016 May; 72(Pt 5):346-55. PubMed ID: 27139825
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Design and synthesis of hydroxyethylamine (HEA) BACE-1 inhibitors: structure-activity relationship of the aryl region.
    Probst GD; Bowers S; Sealy JM; Stupi B; Dressen D; Jagodzinska BM; Aquino J; Gailunas A; Truong AP; Tso L; Xu YZ; Hom RK; John V; Tung JS; Pleiss MA; Tucker JA; Konradi AW; Sham HL; Jagodzinski J; Toth G; Brecht E; Yao N; Pan H; Lin M; Artis DR; Ruslim L; Bova MP; Sinha S; Yednock TA; Gauby S; Zmolek W; Quinn KP; Sauer JM
    Bioorg Med Chem Lett; 2010 Oct; 20(20):6034-9. PubMed ID: 20822903
    [TBL] [Abstract][Full Text] [Related]  

  • 43. High-speed optimization of inhibitors of the malarial proteases plasmepsin I and II.
    Nöteberg D; Schaal W; Hamelink E; Vrang L; Larhed M
    J Comb Chem; 2003; 5(4):456-64. PubMed ID: 12857114
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Identification of potent inhibitors of Plasmodium falciparum plasmepsin II from an encoded statine combinatorial library.
    Carroll CD; Patel H; Johnson TO; Guo T; Orlowski M; He ZM; Cavallaro CL; Guo J; Oksman A; Gluzman IY; Connelly J; Chelsky D; Goldberg DE; Dolle RE
    Bioorg Med Chem Lett; 1998 Sep; 8(17):2315-20. PubMed ID: 9873534
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Dynamic ligand design and combinatorial optimization: designing inhibitors to endothiapepsin.
    Stultz CM; Karplus M
    Proteins; 2000 Aug; 40(2):258-89. PubMed ID: 10842341
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Identification of a small molecule nonpeptide active site beta-secretase inhibitor that displays a nontraditional binding mode for aspartyl proteases.
    Coburn CA; Stachel SJ; Li YM; Rush DM; Steele TG; Chen-Dodson E; Holloway MK; Xu M; Huang Q; Lai MT; DiMuzio J; Crouthamel MC; Shi XP; Sardana V; Chen Z; Munshi S; Kuo L; Makara GM; Annis DA; Tadikonda PK; Nash HM; Vacca JP; Wang T
    J Med Chem; 2004 Dec; 47(25):6117-9. PubMed ID: 15566281
    [TBL] [Abstract][Full Text] [Related]  

  • 47. New inhibitors of the malaria aspartyl proteases plasmepsin I and II.
    Dahlgren A; Kvarnström I; Vrang L; Hamelink E; Hallberg A; Rosenquist A; Samuelsson B
    Bioorg Med Chem; 2003 Aug; 11(16):3423-37. PubMed ID: 12878137
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Optimization of Hydroxyethylamine Transition State Isosteres as Aspartic Protease Inhibitors by Exploiting Conformational Preferences.
    Bueno AB; Agejas J; Broughton H; Dally R; Durham TB; Espinosa JF; González R; Hahn PJ; Marcos A; Rodríguez R; Sanz G; Soriano JF; Timm D; Vidal P; Yang HC; McCarthy JR
    J Med Chem; 2017 Dec; 60(23):9807-9820. PubMed ID: 29088532
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Aminoimidazoles as potent and selective human beta-secretase (BACE1) inhibitors.
    Malamas MS; Erdei J; Gunawan I; Barnes K; Johnson M; Hui Y; Turner J; Hu Y; Wagner E; Fan K; Olland A; Bard J; Robichaud AJ
    J Med Chem; 2009 Oct; 52(20):6314-23. PubMed ID: 19757823
    [TBL] [Abstract][Full Text] [Related]  

  • 50. F2X-Universal and F2X-Entry: Structurally Diverse Compound Libraries for Crystallographic Fragment Screening.
    Wollenhaupt J; Metz A; Barthel T; Lima GMA; Heine A; Mueller U; Klebe G; Weiss MS
    Structure; 2020 Jun; 28(6):694-706.e5. PubMed ID: 32413289
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Structure-based design and synthesis of macrocyclic peptidomimetic beta-secretase (BACE-1) inhibitors.
    Machauer R; Veenstra S; Rondeau JM; Tintelnot-Blomley M; Betschart C; Neumann U; Paganetti P
    Bioorg Med Chem Lett; 2009 Mar; 19(5):1361-5. PubMed ID: 19195886
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Frag4Lead: growing crystallographic fragment hits by catalog using fragment-guided template docking.
    Metz A; Wollenhaupt J; Glöckner S; Messini N; Huber S; Barthel T; Merabet A; Gerber HD; Heine A; Klebe G; Weiss MS
    Acta Crystallogr D Struct Biol; 2021 Sep; 77(Pt 9):1168-1182. PubMed ID: 34473087
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Design, synthesis, and biological evaluation of HIV/FIV protease inhibitors incorporating a conformationally constrained macrocycle with a small P3' residue.
    Mak CC; Le VD; Lin YC; Elder JH; Wong CH
    Bioorg Med Chem Lett; 2001 Jan; 11(2):219-22. PubMed ID: 11206463
    [TBL] [Abstract][Full Text] [Related]  

  • 54. P2'-truncated BACE-1 inhibitors with a novel hydroxethylene-like core.
    Meredith JA; Björklund C; Adolfsson H; Jansson K; Hallberg A; Rosenquist A; Samuelsson B
    Eur J Med Chem; 2010 Feb; 45(2):542-54. PubMed ID: 19995674
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Computational inhibitor design against malaria plasmepsins.
    Bjelic S; Nervall M; Gutiérrez-de-Terán H; Ersmark K; Hallberg A; Aqvist J
    Cell Mol Life Sci; 2007 Sep; 64(17):2285-305. PubMed ID: 17585371
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Design, synthesis and X-ray structure of protein-ligand complexes: important insight into selectivity of memapsin 2 (beta-secretase) inhibitors.
    Ghosh AK; Kumaragurubaran N; Hong L; Lei H; Hussain KA; Liu CF; Devasamudram T; Weerasena V; Turner R; Koelsch G; Bilcer G; Tang J
    J Am Chem Soc; 2006 Apr; 128(16):5310-1. PubMed ID: 16620080
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Structure-guided fragment-based in silico drug design of dengue protease inhibitors.
    Knehans T; Schüller A; Doan DN; Nacro K; Hill J; Güntert P; Madhusudhan MS; Weil T; Vasudevan SG
    J Comput Aided Mol Des; 2011 Mar; 25(3):263-74. PubMed ID: 21344277
    [TBL] [Abstract][Full Text] [Related]  

  • 58. X-ray crystallographic analysis of inhibition of endothiapepsin by cyclohexyl renin inhibitors.
    Cooper J; Quail W; Frazao C; Foundling SI; Blundell TL; Humblet C; Lunney EA; Lowther WT; Dunn BM
    Biochemistry; 1992 Sep; 31(35):8142-50. PubMed ID: 1525155
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Optimization of plasmepsin inhibitor by focusing on similar structural feature with chloroquine to avoid drug-resistant mechanism of Plasmodium falciparum.
    Miura T; Hidaka K; Azai Y; Kashimoto K; Kawasaki Y; Chen SE; de Freitas RF; Freire E; Kiso Y
    Bioorg Med Chem Lett; 2014 Apr; 24(7):1698-701. PubMed ID: 24631188
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Structure-based design and combinatorial chemistry yield low nanomolar inhibitors of cathepsin D.
    Kick EK; Roe DC; Skillman AG; Liu G; Ewing TJ; Sun Y; Kuntz ID; Ellman JA
    Chem Biol; 1997 Apr; 4(4):297-307. PubMed ID: 9195867
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.